Companies: 10,795·Total market cap: $144.5T
Camurus AB (publ)

Camurus AB (publ)

CAMRFOTCHealthcare● Active
$58.00
$-1.70(-2.85%)
Market Cap$3.5B
P/E Ratio
52W High$71
52W Low$55

Camurus AB (publ) (CAMRF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CAMRF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$2.27B$1.87B$1.72B$0.96B$0.60B
Cost of Revenue$0.16B$0.13B$0.12B$0.10B$0.09B
Gross Profit$2.11B$1.74B$1.59B$0.85B$0.52B
Gross Margin %(computed)93.11%93.07%92.87%89.20%85.79%
Operating Expenses
R&D Expenses$0.52B$0.68B$0.64B$0.47B$0.39B
G&A Expenses$0.18B$0.09B$0.05B$0.04B$0.03B
Total Operating Expenses$1.24B$1.27B$1.07B$0.78B$0.63B
Operating Income$0.87B$0.47B$0.53B$0.07B($0.11B)
Operating Margin %(computed)38.58%25.12%30.63%7.52%-18.41%
Interest Income$0.06B$0.08B$0.02B$0.00B$0.00B
Interest Expense$0.01B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.93B$0.55B$0.55B$0.07B($0.11B)
Income Tax Expense$0.20B$0.12B$0.12B$0.02B($0.02B)
Net Income$0.74B$0.43B$0.43B$0.06B($0.09B)
Net Margin %(computed)32.47%22.94%25.13%5.81%-15.06%
Per Share & EBITDA
EPS (Basic)$12.42$7.39$7.50$1.01$-1.66
Wtd Avg Shares0.06B0.06B0.06B0.06B0.05B
EBITDA$0.96B$0.57B$0.56B$0.09B($0.10B)
EBITDA Margin %(computed)42.55%30.43%32.88%9.13%-16.27%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SEK · B

Explore more Camurus AB (publ) data

About Camurus AB (publ) (CAMRF) Income Statement

Camurus AB (publ) (CAMRF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CAMRF reported revenue of $2.27B, gross profit of $2.11B (gross margin 93.11%), and net income of $0.74B — a net profit margin of 32.47%.

Frequently asked questions

CAMRF · 4 questions

Camurus AB (publ) (CAMRF) reported revenue of $2.27B for 2025, up 21.3% year-over-year.

CAMRF revenueCAMRF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09